Mark A. Wilson
Overview
Mark A. Wilson received an average of $3M in total compensation, including $500K in salary, at Nektar Therapeutics between 2020 and 2021.
Source: SEC filings on April 29, 2022 and April 30, 2021.
Related executives
We found 20 more executives who work or worked at Nektar Therapeutics.
Howard Robin
Nektar Therapeutics
Chief Executive Officer
Gil Labrucherie
Nektar Therapeutics
Chief Financial Officer
Jonathan Zalevsky
Nektar Therapeutics
Senior Vice President and Chief Research and Development Officer
John Northcott
Nektar Therapeutics
Senior Vice President and Chief Commercial Officer
Jillian Thomsen
Nektar Therapeutics
Chief Accounting Officer
Stephen Doberstein
Nektar Therapeutics
Chief Research and Development Officer
Maninder Hora
Nektar Therapeutics
Senior Vice President Pharmaceutical Development and Chief Technical Operations Officer
John Nicholson
Nektar Therapeutics